Essential Partners’s Precision BioSciences DTIL Stock Holding History

Essential Partners’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19	Buy	+3	New	+$23	﹤0.01%	2819

Other funds holding DTIL

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Beacon Financial Strategies Raleigh, North Carolina $203M AUM 12.07% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Essential Partners's DTIL Position: Q3 2026 in Review

Essential Partners opened a new position in Precision BioSciences (DTIL) in Q3 2026: 3 shares worth $19. The stake represents ﹤0.01% of the portfolio and ranks #2819 among its holdings.

10 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

Essential Partners held 3 shares of Precision BioSciences worth $19 as of Q3 2026.
Precision BioSciences was a new Essential Partners position in Q3 2026.
Precision BioSciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2819 holding.
10 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.